Evolent Health, Inc. (EVH)
4.90
+0.13
(+2.73%)
USD |
NYSE |
Nov 13, 16:00
4.90
0.00 (0.00%)
After-Hours: 19:59
Evolent Health EPS Diluted (Quarterly) : -0.2084 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.2084 |
| June 30, 2026 | -0.252 |
| March 31, 2026 | -0.238 |
| December 31, 2025 | -3.845 |
| September 30, 2025 | -0.2361 |
| June 30, 2025 | -0.4409 |
| March 31, 2025 | -0.6265 |
| December 31, 2024 | -0.2661 |
| September 30, 2024 | -0.2719 |
| June 30, 2024 | -0.0557 |
| March 31, 2024 | -0.221 |
| December 31, 2023 | -0.3644 |
| September 30, 2023 | -0.2957 |
| June 30, 2023 | -0.3721 |
| March 31, 2023 | -0.2436 |
| December 31, 2022 | -0.1137 |
| September 30, 2022 | 0.0214 |
| June 30, 2022 | -0.0454 |
| March 31, 2022 | -0.0598 |
| December 31, 2021 | 0.0346 |
| September 30, 2021 | -0.152 |
| June 30, 2021 | -0.1066 |
| March 31, 2021 | -0.1383 |
| December 31, 2020 | -0.1735 |
| September 30, 2020 | -0.4385 |
| Date | Value |
|---|---|
| June 30, 2020 | -2.385 |
| March 31, 2020 | -0.9288 |
| December 31, 2019 | -2.360 |
| September 30, 2019 | -0.3045 |
| June 30, 2019 | -0.3842 |
| March 31, 2019 | -0.5891 |
| December 31, 2018 | -0.212 |
| September 30, 2018 | -0.1594 |
| June 30, 2018 | -0.1284 |
| March 31, 2018 | -0.1808 |
| December 31, 2017 | -0.18 |
| September 30, 2017 | -0.18 |
| June 30, 2017 | -0.2842 |
| March 31, 2017 | -0.3424 |
| December 31, 2016 | -0.33 |
| September 30, 2016 | -0.26 |
| June 30, 2016 | -0.20 |
| March 31, 2016 | -2.91 |
| December 31, 2015 | -0.0993 |
| September 30, 2015 | -0.29 |
| June 30, 2015 | 9.73 |
| March 31, 2015 | -0.3174 |
| December 31, 2014 | -0.3019 |
| September 30, 2014 | -0.0881 |
| June 30, 2014 | -0.1222 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DarioHealth Corp. | -0.7337 |
| CompuMed, Inc. | 0.0192 |
| Teladoc Health, Inc. | -0.1481 |
| Renalytix Plc | -- |
| DaVita, Inc. | 3.403 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.57M |
| Revenue (Quarterly) | 725.37M |
| Total Expenses (Quarterly) | 748.93M |
| Enterprise Value | 1.372B |
| Gross Profit Margin (Quarterly) | 9.19% |
| Profit Margin (Quarterly) | -3.25% |
| Earnings Yield | -92.72% |
| Normalized Earnings Yield | -38.51 |